In collaboration with Drs. Paul Bock and Ashok Maddur of Vanderbilt University, and Dr. Pete Panizzi of Auburn University, Green Mountain Antibodies scientists have prepared monoclonal antibodies to the major known procoagulant virulence factors from S. aureus: coagulase and von Willebrand factor binding protein. The rationale behind preparing these antibodies is the hypothesis that blocking fibrin formation in blood following infection, could alter therapeutic outcomes. Kaitlyn Begins of Green Mountain Antibodies is the lead and presenting author. The talk will take place in session 437 on Monday, June 20th, 2016 at 2:45 pm. Click here for further information.
New Antibodies to S. aureus virulence factors to be discussed at American Society of Microbiology meeting in Boston, June 2016.
Previous post: Kaitlyn Begins promoted to Research Project Manager
Next post: Gordon Research Conference on Hemostasis